[1] MASUDA J, KISHI M, KUMAGAI N, et al. Rural-urban disparity in emergency care for acute myocardial infarction in Japan[J]. Circulation, 2018, 82(6):1666-1674. [2] RADWAN H, SELEM A, GHAZAL K, Value of N-terminal pro brain natriuretic peptide in predicting prognosis and severity of coronary artery disease in acute coronary syndrome[J].J Saudi Heart Assoc, 2014, 26(4):192-198. [3] 朱斌, 王永霞.急性冠脉综合症患者冠脉病变与血浆BNP的相关研究[J].求医问药(下半月), 2012, 10(7):305-306. [4] HIKITA H, SHIGETA T, KOJIMA K, et al. Lipoprotein(a) is an important factor to determine coronary artery plaque morphology in patients with acute myocardial infarction[J].Coron Artery Dis,2013, 24(5):381-385. [5] KHAN H A, EKHZAIMY A, KHAN I,et al. Potential of lipoproteins as biomarkers in acute myocardial infarction[J].Anatol J Cardiol, 2017, 18(1):68-74. [6] KOTANI K, SERBAN M C, PENSON P, et al. Evidence-based assessment of lipoprotein(a) as a risk biomarker for cardiovascular diseases-Some answers and still many questions[J].Criti Rev Clin Lab Sci, 2016, 53(6):370-378. [7] REIBIS R, TRESZL A, WEGSCHEIDER K, et al. Disparity in risk factor pattern in premature versus late-onset coronary artery disease:a survey of 15381 patients[J].Vasc Health Risk Manag, 2012, 8:473-481. [8] GENSINI G G. A more meaningful scoring system for determining the severity of coronary heart disease[J].Am J Cardiol, 1983, 51(3):606. [9] MAYR A, MAIR J, SCHOCKE M, et al. Predictive value of NT-pro BNP after acute myocardial infarction:relation with acute and chronic infarct size and myocardial function[J].Int J Cardiol, 2011, 147(1):118-123. [10] CLERICO A, PASSINO C. Predictive value of NT-proBNP in patients with acute myocardial infarction[J].Clin Chem, 2017, 63(5):1045-1046. [11] HARUTYUNYAN M J, MATHIASEN A B,WINKEL P, et al. High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease:A prognostic study within the CLARICOR trial[J].Scand J Clin Lab Invest, 2011, 71(1):52-62. [12] PUELACHER C, WAGENER M, HONEGGER U, et al. Combining high-sensitivity cardiac troponin and B-type natriuretic peptide in the detection of inducible myocardial ischemia[J]. Clin Biochem, 2018, 52:33-40. [13] 王爽,杨水祥,高军毅,等.血浆脑钠肽水平和中心动脉压与冠状动脉病变程度的相关性研究[J].重庆医学, 2014, 43(27):3559-3561,3564. [14] 季燕妮,陈燕春,赵祥海.急性冠脉综合征病人NT-pro BNP水平与冠状动脉Gensini评分的相关性研究[J].中西医结合脑血管病杂志, 2017, 15(22):2914-2935. [15] 江冠颖,赵玉兰,董静,等.左心室射血分数正常的急性ST段抬型心肌梗死患者氨基末端B型利钠原水平与冠状动脉病变的关系[J].中国循环杂志, 2017, 32(2):137-140. [16] SALEHEEN D, HAYCOCK P C,ZHAO W, et al. Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease:A mendelian randomisation analysis[J].Lancet Diabetes Endocrinol, 2017, 5(7):524-533. [17] YANG Q, HE Y M, CAI D P, et al. Risk burdens of modifiable risk factors incorporating lipoprotein (a) and low serum albumin concentrations for first incident acute myocardial infarction[J].Sci Rep, 2016, 6:35463. [18] RALLIDIS L S, PAVLAKIS G, FOSCOLOU A, et al. High levels of lipoprotein (a) and premature acute coronary syndrome[J]. Atherosclerosis, 2018, 269:29-34. [19] TSIMIKAS S. A test in context:lipoprotein(a):diagnosis, prognosis, controversies, and emerging therapies[J]. J Am Coll Cardiol, 2017, 69(6):692-711. [20] 王虹璎,赵红,孙占京,等.脂蛋白a与急性心肌梗死相关性及冠状动脉病变程度及范围的研究[J].中国循证心血管医学杂志, 2019, 11(1):75-78. [21] SCHWARTZ G G, BALLANTYNE C M, BARTER P J, et al. Association of lipoprotein(a) with risk of recurrent ischemic events following acute coronary syndrome:Analysis of the dal-outcomes randomized clinical trial[J]. JAMA Cardiol, 2018, 3(2):164-168. [22] 周辉,王岚峰.脂蛋白(a)与急性ST段抬高型心肌梗死患者冠脉病变严重程度相关性研究[J].现代中西医结合杂志, 2016, 25(25):2761-2764. [23] Gravning J, Smedsrud M K, Omland T, et al. Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome:prediction of significant coronary lesions and long-term prognosis[J].Am Heart J, 2013, 165(5):716-724. [24] 李彦波,刘于红,费月海,等.高龄急性心肌梗死患者临床特点分析[J].国际老年医学杂志,2018,39(1):34-36. |